Hypothyroidism is associated with an increased occurrence of atherosclerosis, suggesting some protective role for thyroid hormones (THs). Hypercholesterolemia is one of the major risk factor to develop this disease. Here, we show that the well-known TH cholesterol lowering effect was dependent on TH nuclear receptor (TR)␤ liver activity. But most importantly, TR␣ was also shown to contribute of slowing down atherosclerosis progression via an independent mechanism. Introduction of TR␣ 0/0 deletion in the ApoE Ϫ/Ϫ background accelerated the appearance of plaques.
Hypothyroidism is associated with an increased occurrence of atherosclerosis, suggesting some protective role for thyroid hormones (THs). Hypercholesterolemia is one of the major risk factor to develop this disease. Here, we show that the well-known TH cholesterol lowering effect was dependent on TH nuclear receptor (TR)␤ liver activity. But most importantly, TR␣ was also shown to contribute of slowing down atherosclerosis progression via an independent mechanism. Introduction of TR␣ 0/0 deletion in the ApoE Ϫ/Ϫ background accelerated the appearance of plaques.
Earlier cholesterol accumulation was detected in aorta macrophages, likely due to impaired cholesterol efflux. The IL-1␤ inflammatory cytokine was elevated in serum and macrophages in correlation with an activation of the AKT/nuclear factor B pathway in these cells. Inhibition of AKT prevented inflammation and restored normal cholesterol efflux. Similar low-grade inflammation was identified in TR␣ 0/0 male mice. Thus, the mere absence of TR␣ is associated with elevated levels of cytokines likely responsible for cholesterol accumulation and atherosclerosis. This TR␣ protective activity should be relevant for other inflammatory pathologies. (Endocrinology 155: 2735-2745,  2014) C ardiovascular diseases (CVDs), including atherosclerosis, are the first cause of death in Western countries. Atherosclerosis is a multistep inflammatory disease characterized at the early steps by accumulation of cholesterol in the arterial wall followed by recruitment of immune cells (macrophages and lymphocytes) (reviewed in Ref. 1) . Hypercholesterolemia and hypertension have been recognized as major risk factors for this disease. Keeping these risks under control is the usual strategy (2) to oppose atherosclerosis progression, with a particular effort to decrease low-density lipoprotein (LDL) cholesterol. Stimulation of reverse cholesterol transport from the aorta to the liver and limitation of the inflammatory response are alternative solutions currently tested. Cholesterol efflux from the aorta to the circulation mainly takes place in cholesterol laden macrophages. Free cholesterol generated from cholesterol ester (CE) hydrolysis (3) is taken up by either apolipoprotein A-I (ApoA-I) or high-density lipoprotein (HDL), respectively, in an ATP-binding cassette transporter A1 (ABCA1)-or ATP-binding cassette trans-porter G1 (ABCG1)-dependent manner (4) . Scavenger receptor class B member allows cholesterol uptake but is also involved in HDL-mediated efflux. ABCA1 or ABCG1 dysfunctions lead to increased foam cell formation and accelerated atherosclerosis progression (5) . Inflammation has recently been recognized to be central for the initiation and the progression of many metabolic diseases, including atherosclerosis. Upon different metabolic stresses, the proinflammatory cytokine IL-1␤ is produced and secreted, leading to the amplification of the inflammatory process characterized by the synthesis of other cytokines, such as TNF-␣. Inhibition of the IL-1␤ pathway protects mice from atherosclerosis (6, 7) . The production of active IL-1␤ is a 2-step process involving the stimulation of IL-1␤ expression and its activation by caspase-mediated cleavage (8) . Nuclear factor B (NF-B) is a master regulator of the inflammatory response (9) . Its nuclear localization and activity induces the expression of many cytokines, including IL-1␤. AKT, as well as many other kinases, is activated in response to inflammatory signals to promote NF-B activity.
Human observation studies suggested that patients with overt hypothyroidism display an increased incidence of CVD and coronary atherosclerosis (10), findings that are now supported by metaanalyses (11, 12) . Subclinical hypothyroidism was even identified in the Rotterdam Study (13) as an independent risk factor for CVD. Thus, the adverse effect of hypothyroidism on CVD outcome is well established, but it is still unclear whether low concentrations of thyroid hormone (TH) induce atherosclerosis by other means than increasing LDL levels. Conversely, THs efficiently decrease blood cholesterol but are excluded as a therapeutic tool given their deleterious actions on other organs (14) .
TH actions are mediated by the TH nuclear receptors (TRs) TR␣ and TR␤ (15) , which mainly work as transcription factors. However, TR can also be active in the cytoplasm, where they interact and can activate different kinases (16) , including AKT. The expression patterns of TR␣ and TR␤ are only partially overlapping (17) , and each subtype fulfils specific functions. TH regulation of serum cholesterol level is TR␤ dependent as demonstrated by the study of TR␤ knockout (KO) (18) mice and the action of TR␤ agonists (19) . These agonists strongly lower LDL cholesterol in humans, both on their own and in synergy with statins (20) . As expected, these drugs slow down atherosclerosis progression in animal models. TR␣ is expressed at low level in the liver, and its deletion does not impact either cholesterol metabolism in the liver nor serum concentration (18) . In contrast, TR␣ expression is much higher in other organs or cells (heart, brown adipose tissue, vascular smooth muscle cells, and bone marrow
[BM]-derived cells), in which TR␣ activity could impact the level of atherosclerosis risk factors or atherosclerosis development. Accordingly, several TR␣KO mice models display bradychardia (21) and metabolic phenotypes. TR␣ 0/0 mice (22) used in this study are whole-body KO of the TR␣ locus. They do not express either TR␣1 or the 3 other non-TH receptor proteins TR␣2, TR⌬␣1, and TR⌬␣2. They are resistant to obesity and remain insulin sensitive under Western-type diet (WTD) (23) . Their lean phenotype results from increased energy expenditure developed to maintain body temperature despite dysfunctional brown adipose tissue (24) .
The function of TR in the hematopoietic system and as regulators of the inflammatory response has been poorly studied. High levels of inflammation markers have been observed in the skin but also in fibroblasts isolated from TRKO mice (25) . This enhanced inflammatory response was correlated with the activation of AKT and of the NF-B pathway, suggesting that TR could have anti-inflammatory functions in given cell types. Conversely, it was very recently described that TH would limit inflammation in macrophages and increased the survival rate after lipopolysaccharide (LPS) exposure (26) .
The present study was designed to assess whether 1) TH regulation of cholesterol metabolism was entirely dependent on TR␤ hepatic activity and 2) in addition to this hypocholesterolemic action TH could regulate some other function(s), via TR␣, that could participate to their slowing down atherosclerosis progression. To these ends, liverspecific TR␤KOs (TR␤LKOs) were generated, and the TR␣ 0/0 deletion was introduced in the ApoE Ϫ/Ϫ background, classically used to study this disease. The results demonstrate that 1) liver TR␤ is necessary for TH to reduce blood cholesterol levels and 2) TR␣ protects against atherosclerosis progression by limiting inflammation and allowing an efficient cholesterol efflux.
Materials and Methods

Animals and preparation of tissue samples
TR␤ flox/flox mice (mixed C57BL/6/129/SV) were generated in the lab (27) and crossed with Alfp-cre mice (mixed C57BL/6/ 129/SV) (28) , which were kindly provided by Günther Schütz, to selectively abrogate TR␤ expression in the liver. The AlfP "promoter" is composed of an Alfp-enhancer element fused with the albumin promoter and drives Cre-recombinase expression in hepatocytes from embryonic life. Alfp-creTR␤ flox/flox are referred as TR␤LKO in the text. TR␤ flox/flox mice obtained from the same cross were used as their wild-type (WT) control. TR␣ 0/0 (sv129) (22) and ApoE Ϫ/Ϫ mice (C57BL/6) were crossed together. TR␣ 0/0 , ApoE Ϫ/Ϫ TR␣ 0/0 , and ApoE Ϫ/Ϫ issued from these crosses were kept to obtain the different KO and controls in a same genetic background. TR␣ 0/0 (C57BL/6) KO were ob-tained after more than 10 backcrosses in the C57bl6 background. Animals were fed a chow diet (CD) (T7001; Harlan Teklad) and housed under recommended conditions. For experiments, 6-to 8-week-old mice were either kept on this CD or switched to an atherogenic WTD (TD88137; Harlan Teklad) when mentioned. TH deficiency was induced in adult animals with a propylthiouracil (PTU)-containing diet (TD95125; Harlan Teklad) and followed or not by TH (mix of T 4 and T 3 ) injection as previously described (29) . Only males were used for all experiments, as usually the case for metabolic studies, in order to avoid potential interference with sexual hormonal signaling. Animals were killed by cervical dislocation, blood was collected for serum preparation, and tissues were dissected and stored adequately for different applications. All animal experiments were performed under animal care procedures and conducted in accordance with the guidelines set by the European Community Council Directives (86/609/EEC).
BM transplantation
Male mice (6-to 8-week-old) from either ApoE Ϫ/Ϫ (n ϭ 12) or ApoE Ϫ/Ϫ TR␣ 0/0 (n ϭ 12) were lethally irradiated with 9.5 Gy and reconstituted by retroorbital injection of 10 6 BM cells prepared from either ApoE Ϫ/Ϫ (n ϭ 6) or ApoE Ϫ/Ϫ TR␣ 0/0 (n ϭ 6) male donors. Ten days after grafting, mice were switched to WTD.
Cell culture and in vitro cholesterol efflux
Macrophages were differentiated in vitro from male mice BM (bone marrow derived macrophages, BMDM) in complete medium (RPMI 1640; Life Technologies), 10% fetal calf serum (Life Technologies), and 15% L929-cell conditioned medium for 8 -10 days. Before experiments, they were switched to RPMI 1640 medium containing 10% lipid-depleted serum (HyClone). Cholesterol efflux was performed as previously described (30) . When indicated, cells were treated with LPS (1 g/mL; SigmaAldrich) or Akt inhibitor (10 g/mL; Sigma-Aldrich) for the indicated time period.
Physiological parameters
Sera were assayed for cholesterol (total and HDL) and triglycerides (KonelabAb 20i [Thermoscientific] or Cobas c501 [clinical chemistry analyzers; Roche]). LDL was calculated according to the Friedwald equation. Inflammation markers were detected using the milliplex map mouse cytokine/chemokine panel kit (Millipore) on a Bioplex 100 apparatus (Bio-Rad). This same kit was used to detect the cytokines in BMDM supernatants. Blood pressures (BPs) were measured using the CODA computerized noninvasive tail cuff system (Kent Scientific) on vigil mice (n Ն 6).
Analysis of atherosclerosis progression
Detection of atherosclerosis in the aortic roots was performed using the high-resolution ultrasound (US) imaging system Vevo 770 with a 30 MHz scannhead (Visualsonics) on anesthetized male mice (n Ն 6 for each group). We counted plaques in each mouse by scanning the aortic arch in the long axis, enlarging to the ascending aortic arch, innominate artery, and left common carotid artery to the carotid bifurcation. Plaque area was measured using sagittal and transversal views by B-mode US. Aortas were also characterized by classical-and immuno-histology.
Cholesterol extraction and quantification from tissues and cells
Total cholesterol was extracted from liver by the Folch method and quantified using the DIASYS reagent (Diagnostic Systems GmbH). Total cholesterol from aortas or BMDM was extracted with chloroform:isopropanol to determine the amount of the different forms of cholesterol using the cholesterol/CE quantitation kit (Calbiochem, Merck4Biosciences).
RNA extraction and expression analyses by relative quantitative RT-PCR (QRT-PCR)
Total RNA preparation, reverse transcription, and semi-QRT-PCR were performed and analyzed as previously described (31) . 36B4 was always used as the reference gene, and the control group was either ApoE Ϫ/Ϫ CD-fed mice and ApoE Ϫ/Ϫ vehicletreated macrophages, WT CD-fed male mice and WT vehicletreated macrophages, or WT PTU-fed male mice. The sequences for the different primers used are listed in Supplemental Table 1 .
Immunofluorescence
BMDM were fixed with 4% paraformaldehyde, rinsed, and permeabilized in 0.5% Triton X-100 PBS. After saturation with 5% BSA PBS, cells were incubated with primary anti-p65, a subunit of NF-B (sc-109; Santa Cruz Biotechnology, Inc), antibodies in 1% BSA PBS. Samples were then exposed to the Alexa Fluor 555-conjugated goat antirabbit IgG (A-21430; Life Technologies) secondary antibody. 4Ј,6-Diamidino-2-phenylindole (DAPI) was included in the mounting medium (SouthernBiotech). Fluorescence was examined under a Zeiss AxioImager microscope (Zeiss) using the Zeiss Axiovision 4.4 software. 
Nuclear extracts, whole-cell lysates, and Western blottings
Data analysis
Data are presented as mean. Comparisons between 2 groups were performed using an unpaired Student's t test (physiological, biochemistry, and histological data). Statistical relevance was determined using the one-way variable ANOVA method for QRT-PCR and cell/tissue/serum cholesterol content data. For mice experiments, the error bars represent ϮSEM, for cell culture ϮSD. Differences of P Ͻ .05 were considered significant. A dollar doi: 10.1210/en.2014-1098 endo.endojournals.orgsymbol indicates significant difference between 2 genotypes under the same diet or treatment, whereas an asterisk indicates significant difference between diets or treatment for a given genotype.
Results
TR␤ liver-specific deletion prevents TH lowering of serum cholesterol It was assumed in the literature that TR␤ action in the liver was crucial for TH regulation of serum cholesterol. However, no formal evidence was available, because most of TR␤-selective agonists could also target other tissues. TR␤ liver-selective KO male mice were generated. As expected, they present normal levels of circulating free T 3 and T 4 ( Figure 1A ). The expression of TR␤1, the only TR␤ isoform expressed in the liver, was efficiently reduced in this tissue but not in any of the other tested as expected ( Figure 1B) . On a CD, TR␤LKO mice present normal levels of circulating cholesterol ( Figure 1C ). Serum cholesterol level was lower in TR␤LKO male mice than in WT under hypothyroid conditions, and TH injection significantly reduced this parameter both in controls (3.2-fold) and in TR␤LKO (1.2-fold). The response to TH was thus severely blunted in TR␤LKO and TH remaining action likely due to the residual TR␤ expression ( Figure 1B) . The inadequate response of TR␤LKO was correlated to the inability of TH to up-regulate the expression of Cyp7a1 ( Figure 1D ). Hepatic TR␤ expression is thus necessary for hypothyroidism-linked hypercholesterolemia and TH hypocholesterolemic action.
TR␣ deletion accelerates atherosclerosis development in an ApoE
؊/؊ background without increasing the risk factors for this disease We then aimed to determine whether TH could have additional protective effect against atherosclerosis development. We focused on potential TR␣-mediated actions to prevent interference with the regulation of lipid metabolism.
KO (ApoE Ϫ/Ϫ TR␣ 0/0 ) and control (ApoE Ϫ/Ϫ ) male mice were either fed a CD or a WTD to favor atherosclerosis. Importantly, circulating levels of TH were marginally affected (Supplemental Figure 1A) in KO. As previously shown in a SV129 background, TR␣ 0/0 was associated in the ApoE Ϫ/Ϫ background to slightly lower T 4 and higher T 3 levels (32). These small variations should allow observing the consequences of TR␣ absence in the context of a normal TR␤ activity as it was the case for all precedent published studies using TR␣ 0/0 animals. The 2 major risk factors, hypercholesterolemia and hypertension, were monitored. The lipid profiles were identical in ApoE Figure 1B) . BP was slightly lower or similar in KO as compared with controls, respectively, on CD and after 8 weeks of WTD (Supplemental Figure 1C) . Thus, the TR␣ 0/0 deletion did not aggravate any of the risks tested in the ApoE Ϫ/Ϫ background.
Atherosclerosis progression was checked using high-sensitivity US. Typical images are shown on Figure  2A . The accuracy and the sensitivity of the US method were validated by Figure 1 . TR␤ liver-specific deletion prevents TH lowering of serum cholesterol. Sera (A and C, left panel) and organs (B-D) were sampled from 2-to 3-month-old WT and TR␤LKO male mice (n ϭ 6). Serum concentration of free T3 (FT3) (A), free T4 (FT4) (A), and total cholesterol (C, left panel) was measured. The expression of TR␤ in different tissues (liver, white adipose tissue, brown adipose tissue, and skeletal muscle) was assessed by semi-QRT-PCR (B). Two-to 3-monthold WT and TR␤LKO male mice were fed a PTU-containing diet to induce hypothyroidism (n ϭ 28 per genotype) and injected (n ϭ 14) or not (n ϭ 14) with TH. Serum total cholesterol (C, right panel) was measured. The liver expression of TR␤ as well as 1 of its well-known target cyp7a1 was assessed by semi-QRT-PCR (D). $, P Ͻ .05; $$, P Ͻ .005; $$$, P Ͻ .0005; $$$$, P Ͻ .00005; $$$$$, P Ͻ .00005; *, P Ͻ .05; **, P Ͻ .005; ***, P Ͻ .0005; ****, P Ͻ .00005; *****, P Ͻ .00005.
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killing mice at different time points and identifying lesions in dissected aortas after classical staining. All aortas in which lesions had been identified by US displayed obvious plaques upon histological examination (Figure 2A ), an observation which validates the technique. However, fatty streaks, characteristic of the very early step of atherosclerosis, were only detected by histology, showing that US was less sensitive (data not shown). This lower sensibility accounts for the apparent delay registered for the apparition of lesions in the ApoE Ϫ/Ϫ mice in our experiments as compared with other published studies.
Lesions appeared much earlier in the KO under both diets ( Figure 2B ). After 8 weeks of WTD, 40% of the KO displayed lesions in their aortas, and all of them were affected after 16 weeks, the first time point when lesions could be detected in few controls (17%). Strikingly, 30% of the KO also presented lesions under CD at the later time points, whereas none were identified in controls. The precise numbers of animals tested and presented with lesions are reported in Supplemental Table 2 . This precocious and massive accumulation of lesions was confirmed by Oil Red O coloration in en face views of the aortas ( Figure 2C ) and dosing cholesterol after its extraction from whole aortas ( Figure 2D) . Moreover, the number of lesions per animal and the area of a given lesion were more important in ApoE Ϫ/Ϫ TR␣ 0/0 than in ApoE Ϫ/Ϫ ( Figure 2E ).
Thus, the TR␣ 0/0 deletion favors atherosclerosis plaque formation in the absence of any elevation of the conventional risk factors in the ApoE Ϫ/Ϫ background.
TR␣ deletion leads to the specific accumulation of cholesterol in aortas as a result of deficient cholesterol efflux from macrophages
Macrophages are central for cholesterol homeostasis during atherogenesis. Their failure to properly ensure cholesterol efflux for reverse cholesterol transport leads to aggravated atherosclerosis in different models (5) . Cholesterol accumulation in ApoE Ϫ/Ϫ TR␣ 0/0 was limited to aortas ( Figure 3A ) and was not observed in other organs, such as liver. Staining of adjacent sections of aorta with Oil Red O staining or monocyte macrophage 2 (Moma2) antibody for macrophage identification showed that lipids mostly accumulated in these cells ( Figure 3B ).
The impact of the TR␣ 0/0 deletion on the ability of macrophages to take up and efflux cholesterol was tested in vitro in BMDM. The deletion did not modify the efficiency of cholesterol uptake from acetylated LDL (Ac-LDL) but strongly impaired cholesterol efflux to an ApoA-I acceptor ( Figure 3C) . Remarkably, the expression of ABCA1, the transporter specifically required for ApoA-I-mediated efflux, was lower in KO BMDM as compared with controls in all tested conditions. The expressions of ABCG1 and SR-B1 that are also involved in the efflux pathway but using HDL as an acceptor were not decreased, the latter was even slightly more abundant in KO in unloaded conditions (Supplemental Figure 2) . These data suggest that in the ApoE
, but also in a C57BL/6 genetic background (Supplemental Figure 3A) , the TR␣ deletion triggers accumulation of CEs in macrophages due to impaired cholesterol efflux. In the C57BL/6 genetic background, ABCA1 expression was normal, suggesting that lower ABCA1 expression in ApoE Ϫ/Ϫ TR␣ 0/0 might not be responsible for the reduced efflux.
The hematopoietic compartment is involved in the proatherosclerosis effect of the TR␣ deletion
Atherosclerosis is an inflammatory disease, and several immune cell types are involved in disease progression, including macrophages that were shown to be defective for cholesterol efflux at least in vitro when TR␣ was deleted (Figure 3) . To evaluate whether in vivo dysfunctional hematopoietic cells were responsible for accelerated atherosclerosis in ApoE Ϫ/Ϫ TR␣ 0/0 , both control and KO male mice were irradiated and reconstituted with either KO or control BM from male mice (Figure 4) . Graft of KO BM led to more atherosclerosis in both receiver backgrounds as compared with control BM, as visualized by a larger area under the curves for a given genotype of receiver in the KO BM grafted animals. Most importantly, control mice reconstituted with the KO BM displayed plaques more frequently at the 4 time points tested (4, 6, 12, and 16 wk of WTD) than those reconstituted with control BM. The TR␣ deletion limited to the myeloid compartment is thus sufficient to recapitulate (although to a lesser extent) the atherosclerosis phenotype of ApoE Ϫ/Ϫ TR␣ 0/0 animals. The similar results obtained with the 2 different BM in the KO background at the early time point suggest that TR␣ also fulfills functions outside of the myeloid cells that impact on atherosclerosis. A higher sensitivity of the KO to irradiation, as a consequence of defective DNA damage reparation previously described for TR␣ 0/0 mice (33), might be responsible for the early appearance of plaques in this background as compared with control receivers. Indeed, irradiation and its associated damages were shown to accelerate atherosclerosis (34) .
The precise number of animals tested and presented with lesions was reported in Supplemental Table 2 .
The TR␣ 0/0 deletion limited to the BM was thus sufficient to provoke an acceleration of atherosclerosis progression, but this deletion also likely impacted on other organs involved in the disease. 
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Billon et al TR␣ Protects Against Atherosclerosis Endocrinology, July 2014, 155 (7): [2735] [2736] [2737] [2738] [2739] [2740] [2741] [2742] [2743] [2744] [2745] Inflammation is increased by the TR␣ deletion both in vivo and in BMDM BM-derived cells, such as macrophages but also neutrophils, are important producers of cytokines that have been involved in atherosclerosis (3) progression, including TNF-␣ and IL-1␤.
Higher expression of these 2 pro-inflammatory cytokines was detected in KO aortas ( Figure 5A ) or BMDM ( Figure 5B ) as compared with controls. WTD feeding increased the expression of TNF-␣ and IL-1␤ in both genotypes in agreement with the hypercholesterolemic feature of this diet and thus its pro-inflammatory action. As expected, cholesterol loading triggered a slightly higher expression of inflammatory markers in control but not KO macrophages. Taken together, these data show that in aorta, as recently reported in skin (25) , TR␣ deletion increases local inflammation. This inflammation could be observed before any lesion or macrophage was detectable, suggesting that at this point, they were likely produced by endothelial cells or vascular smooth muscle cells. However, KO macrophages also expressed these signaling factors at higher levels pointing to a broader activity of TR␣ as an anti-inflammatory agent. This broader action was supported by the high concentration of several cytokines (IL-1␤, IL-6) in the serum of CD-fed KO ( Figure 5C ). Similar inflammatory signature was found in the serum (Supplemental Figure 3D ) and the aortas (Supplemental Figure  3B) as well as in the supernatant and cell extracts of BMDM (Supplemental Figure 3C ) from TR␣ 0/0 in a C57BL/6 background. It clearly demonstrates that lowgrade inflammation resulting from the absence of TR␣ is not the result of an inappropriate cholesterol burden.
TR␣ deletion enhances nuclear localization and activity of the inflammatory master regulator NF-B
NF-B is a major transcription factor regulating the inflammatory response. In absence of specific signal, it is mainly trapped in the cytoplasm by inhibitor of NF-B (IB). Upon an inflammatory stimulus, and after kinase activation, such as AKT, phosphorylated IB dissociates from the p65 (RelA) subunit of NF-B that relocalizes in the nucleus, where it triggers expression of numerous cytokines (35) . BMDM in culture were used for both immunofluorescence and Western blottings on nuclear extracts ( Figure 6A ). Both assays showed that p65 was more abundant in the nuclei of KO as compared with controls in absence of any inflammatory stimulus. Moreover, AKT was also more phosphorylated in the KO in these same conditions ( Figure 6B ) allowing the phosphorylation of downstream target such as p65 ( Figure 6C ). This increase in AKT phosphorylation was critical for the observed accumulation of NF-B in the nucleus, because it was prevented by an AKT inhibitor ( Figure 6D ). In the presence of this inhibitor, NF-B was found in the cytoplasm in the mutants as in the controls under both treatments.
LPS, a potent inflammation inducer, increased p65 in the nucleus of both genotypes and was used as a positive control. In other studies, AKT activity has been shown to be directly regulated by cytoplasmic TR␣ (25, 36) . Interaction between endogenous AKT and TR␣ was tested by immunoprecipitation in unstimulated BMDM but could not be detected. Importantly, the inhibition of AKT also normalized the efflux of cholesterol to ApoA-I in BMDM from KO to control levels without modifying its up-take ( Figure 6D ). This result suggests that inflammation could be responsible for reduced cholesterol efflux, but a direct effect of AKT on efflux could not be excluded.
Discussion
Hypothyroidism is clearly associated with higher incidence of CVD and atherosclerosis. The present results demonstrate that 1) hepatic TR␤ is central for the regulation of serum cholesterol associated with either hypo-or hyperthyroidism, 2) TR␣ protects against atherosclerosis without affecting cholesterol levels or BP, risk factors known to be under TH control, and 3) TR␣ is critical to avoid low-grade inflammation in mice. Hypercholesterolemia has long been associated with hypothyroidism. We demonstrate here that TR␤1 expression in the liver was necessary to observe the increase in serum cholesterol concentration at low level of TH as well as to restore this concentration to normal after TH injection. These results strongly suggest that most of TH regulation of cholesterol metabolism is taking place in the liver via TR␤1, excluding major effect of TH on transintestinal cholesterol excretion, another major route for cholesterol elimination (37) . Two recent studies (38, 39) demonstrated that TH lipid lowering action was unaffected in LDLR Ϫ/Ϫ mice, with no up-regulation of any other lipoprotein receptors in liver. Together with our results, this points to conversion of cholesterol into bile acids for elimination as the likely preponderant mechanism. In agreement with this model, the up-regulation of Cyp7a1 expression by TH was blunted in the TR␤LKO. TR␤-selective agonists targeted to the liver would thus be good candidates to limit hypercholesterolemia in particular in patients harboring homozygous LDLR mutations. Accordingly, TR␣ deletion did not modify circulating cholesterol levels. However, it did highly accelerate atherosclerosis development in the ApoE Ϫ/Ϫ background. BP, the other risk factor known to be affected by TH levels, was not modified in the KO mice. Hypertension has been linked both to hypo-and hyperthyroidism, the absence of a significant increase of BP in ApoE Ϫ/Ϫ TR␣ 0/0 KO argues against a specific role for TR␣ in its regulation.
Although no risk factor was aggravated in the ApoE Ϫ/Ϫ TR␣ 0/0 male mice as compared with ApoE Ϫ/Ϫ , these mice presented low-grade inflammation under CD. Their serum concentration of the pro-inflammatory cytokine IL-1␤ was significantly elevated. Local expression of both IL-1␤ and its target gene TNF-␣ was also elevated in the aortas of these mice. Hypercholesterolemia is not responsible for this low-grade inflammation, because the same Figure 6 . The pro-inflammatory state associated to TR␣ deletion in macrophages involves an AKT-dependent activation of the NF-B pathway. BMDM from ApoE Ϫ/Ϫ or ApoE Ϫ/Ϫ TR␣ 0/0 male mice were fixed and stained for immuno-fluorescence with an anti-RelA/p65. A, Ratio of the cells presenting nuclear instead of cytoplasm localization RelA/p65 was measured (n ϭ 100 cells) (A left panel). Nuclear extracts of similarly treated BMDM were analyzed by Western blotting and revealed by either an anti-RelA/p65 or an antihistone H3 antibody as a control of loading. LPS (1 g/mL for 8 h)-treated cells were added as a positive control because LPS is known to relocalize RelA/p65 in the nucleus (A, right panel). B and C, Whole-cell lysates from ApoE Ϫ/Ϫ or ApoE Ϫ/Ϫ TR␣ 0/0 BMDM cultured in regular medium were analyzed by Western blotting for phospho-AKT and total AKT (B) or phospho-AKT and phospho-p65 (C). Two different BMDM preparations of each genotype were used for this latter Western blotting (C). Actin and histone H3 were, respectively, used as control in B and in C. A quantification of the signal is provided for C. D, BMDM from ApoE Ϫ/Ϫ or ApoE Ϫ/Ϫ TR␣ 0/0 male mice were exposed to an Akt inhibitor (AKTi, 1M) or DMSO for 30 minutes and harvested after 2 hours. BMDM from both genotypes were treated with LPS (1 g/mL for 8 h) as a control. After cell fractionation, both cytoplasmic and nuclear fractions were analyzed by Western blotting and revealed with anti-RelA/p65, an antihistone H3, and an anti-␤-tubulin. Histone H3 is a nucleus marker and ␤-tubulin a cytoplasmic marker, and they are both used to assess the quality of the fractionation and as control of loading in their respective compartment. A quantification of the signal is provided. E, The ability of these BMDM (n ϭ 3 for each condition) to up-take cholesterol from Ac-LDL (left panel) and to efflux it to ApoA-I (right panel) was measured. Data are represented as mean Ϯ SD. $ or *, P Ͻ .05.
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Billon et al TR␣ Protects Against Atherosclerosis Endocrinology, July 2014, 155 (7) We used macrophages as a model system to better understand the mechanisms linking TR␣ to inflammation. In these cells, TR␣ deletion triggers AKT phosphorylation that is responsible for the activation of NF-B that in turn increases the expression of numerous cytokines, including IL-1␤. The production of IL-1␤ is recognized as an early step of inflammation already targeted in human inflammatory diseases by Anakinra, and for which clinical trials are underway for metabolic diseases such as diabetes or atherosclerosis (40) .
A direct interaction between AKT and TR has been described in other cell types. Such cytoplasmic actions of TR␣ have been suggested in the skin (25) and for the regulation of AKT by TR␤ in the ␤ cell of the pancreas (36) . However, at this point, we failed to identify a direct interaction between endogenous AKT and TR␣ in macrophages. However, due to the poor quality of the TR␣ antibody available to us, this hypothesis cannot be fully excluded. Our hypothesis is that in absence of TR␣, AKT is activated leading to the nuclear relocalization of NF-B and the production of IL-1␤. This cytokine could in turn signal to the IL-1R and amplify the inflammatory reaction as demonstrated in other systems. This hypothesis is currently under investigation in the lab.
Specific CE accumulation was present in macrophages from both ApoE Ϫ/Ϫ TR␣ 0/0 and TR␣ 0/0 male mice likely as a result of deficient cholesterol efflux characterized in vitro. This default was associated to atherosclerosis in the former but not the latter (Supplemental Figure 3B ) due to the well-known resistance of mice to this disease in absence of "artificially" elevated levels of circulating cholesterol brought by the ApoE Ϫ/Ϫ background. Our attempt to block inflammation using AKT inhibitor restored cholesterol efflux without affecting ABCA1 expression. The hypothesis is now that abnormal accumulation and efflux of cholesterol directly result from increased inflammation as already published by others (41) (42) (43) . IL-1␤ in particular has clearly been associated to CE accumulation in both fibroblasts and macrophages (41, 42) . A decrease in ABCA1 expression has been suggested, but this is still not well documented. In our study, the efflux to ApoA-I was impaired, suggesting that the ABCA1-dependent pathway is also affected. Further studies are needed to determine the exact step targeted. However, any direct action of activated AKT on cholesterol should be experimentally excluded. If verified, our hypothesis implies that avoiding the inflammatory state in the ApoE Ϫ/Ϫ TR␣ 0/0 male mice should prevent their accelerated development of atherosclerosis.
As mentioned before, expression of inflammation markers, especially IL-1␤ but also TNF-␣, was higher in the aortas of CD-as well as WTD-fed ApoE Ϫ/Ϫ TR␣ 0/0 before any macrophages could be detected. This observation, combined with the effect of TR␣ deletion in the recipient background in the mouse chimera experiments, strongly suggests that TR␣ also modulates inflammation in other cells (inflammatory or not). Finally, because the TR␣ locus encodes other proteins than TR␣1, we cannot exclude at this point that TR␣2, the only other product of the gene found expressed in BMDM (Supplemental Figure 4) , could be involved in the regulation of inflammation and/or cholesterol efflux.
Conclusion and Perspectives
The present data established TR␣ as a protective factor against atherosclerosis progression. Most importantly, these results highlight the important role of TR␣ in the macrophage that was unsuspected to date, as a gatekeeper of inflammatory processes. The anti-inflammatory properties of TR␣, also identified in the fibroblasts (25) , suggest that this receptor could be protective in other inflammatory contexts, such as metabolic or pathogens related diseases. Given the potential clinical impact of this finding, more studies are ongoing to understand the extent and the basis for TR␣ regulation of inflammatory processes.
